Anthropic 收购一人生物科技公司 Mithril Medicine，正式开展药物发现业务。其创始人 Cody Tranbarger 用 Claude 协调 11 个外部实验室的合同、物流和实验，不到 18 个月将一种罕见肌营养不良症的潜在疗法从想法推进到小鼠上的初步成果，预计最快 2028 年底启动人体临床试验。作者认为药物发现将成为重要收入来源，且消息在 IPO 前发布时机刻意。
A few thoughts on Anthropic’s approach:
1. Drug discovery will be one of the most significant revenue streams in the future; the goal here is to set the right course early on. Most diseases will become treatable, a market encompassing 7 billion people.
2. The timing is clearly intentional, announced just before the IPO to signal to investors that the business will continue to thrive in the future.
3. This will likely make it clear, even to those outside the "tech nerd" sphere, why AI is so important. It goes beyond just writing code; it solves problems for humanity.
Anthropic is now doing its own drug discovery after acquiring one-person biotech startup Mithril Medicine! With Claude and 11 external labs, its founder took a potential treatment for a rare form of muscular dystrophy from idea to promising results in mice in under 18 months.在 X 查看被引用的帖子
来源：Chubby♨️ · x.com